Clinical Trial Update: Rituximab for Pediatric Renal Transplant Rejection [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating rituximab for pediatric kidney transplant rejection have completed. The study investigates rituximab as an immunomodulator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection
• Kidney Transplantation

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Stanford University | Conditions: Kidney Transplantation | Phase 2, Phase 3 | Status: COMPLETED